SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001723128-19-000007
Filing Date
2019-01-07
Accepted
2019-01-07 16:35:04
Documents
2
Period of Report
2019-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_154689688579285.html 3  
1 FORM 3 wf-form3_154689688579285.xml 3 2316
2 POWER OF ATTORNEY - BUCHEN buchensection16powerofatto.htm EX-24 8638
  Complete submission text file 0001723128-19-000007.txt   12185
Mailing Address
Business Address
BUCHEN DAVID A (Reporting) CIK: 0001241751 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38485 | Film No.: 19513737

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences